|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2000-01-11 |
A Phase 2, Double-Masked, Randomized, Vehicle-controlled Trial Evaluating the Efficacy and Safety of Cevimeline Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease
This study will be a randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group study to evaluate the efficacy, safety and tolerability of repeat dosing of Cevimeline Ophthalmic Solution compared to the vehicle in subjects with Dry Eye Disease (DED).
100 项与 Biotheravision, Inc. 相关的临床结果
0 项与 Biotheravision, Inc. 相关的专利(医药)
100 项与 Biotheravision, Inc. 相关的药物交易
100 项与 Biotheravision, Inc. 相关的转化医学